FR2480779B2
(fr)
|
1979-08-30 |
1986-07-18 |
Anvar |
Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur
|
US6096879A
(en)
|
1978-12-18 |
2000-08-01 |
Institut Pasteur |
Nucleotide sequence comprising the genome of hepatitis B virus, nucleotide sequence coding the surface antigen of the hepatitis B virus, vectors containing the nucleotide sequences, process for the preparation thereof, and antigen obtained thereby
|
US6297355B1
(en)
|
1978-12-22 |
2001-10-02 |
Biogen, Inc. |
Polypeptides displaying HBV antigenicity or hbv antigen specificity
|
US5196194A
(en)
|
1979-05-24 |
1993-03-23 |
The Regents Of The University Of California |
Vaccines containing Hepatitis B S-protein
|
ES2167304T3
(es)
|
1987-06-22 |
2002-05-16 |
Medeva Holdings Bv |
Peptido que contiene el antigeno de superficie de la hepatitis b.
|
US6607727B1
(en)
*
|
1991-08-26 |
2003-08-19 |
The Scripps Research Institute |
Peptides for inducing cytotoxic T lymphocyte responses to hepatitus B virus
|
US6297048B1
(en)
|
1992-02-04 |
2001-10-02 |
Chiron Corporation |
Hepatitis therapeutics
|
US6174666B1
(en)
|
1992-03-27 |
2001-01-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of eliminating inhibitory/instability regions from mRNA
|
US5595739A
(en)
|
1993-05-07 |
1997-01-21 |
Abbott Laboratories |
Hepatitis B virus mutants, reagents and methods for detection
|
GB9401987D0
(en)
|
1994-02-02 |
1994-03-30 |
Imperial College |
Modified nucleic acid
|
US7732423B2
(en)
|
1994-04-27 |
2010-06-08 |
Institut Pasteur |
Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis
|
WO1996012027A1
(en)
|
1994-10-18 |
1996-04-25 |
Scottish Crop Research Institute |
Method of producing a chimeric protein
|
JPH11508766A
(ja)
|
1995-06-20 |
1999-08-03 |
ザ・ジェネラル・ホスピタル・コーポレイション |
B型肝炎複製の抑制
|
ZA973367B
(en)
|
1996-04-19 |
1997-11-18 |
Innogenetics Nv |
Method for typing and detecting HBV.
|
AU4248297A
(en)
|
1996-09-03 |
1998-03-26 |
General Hospital Corporation, The |
Inhibition of viral replication
|
EP0919568A1
(en)
|
1997-12-01 |
1999-06-02 |
Sorin Diagnostics S.r.l. |
Escape mutant of the surface antigen of hepatitis B virus
|
FR2775435B1
(fr)
|
1998-02-27 |
2000-05-26 |
Bioalliance Pharma |
Nanoparticules comprenant au moins un polymere et au moins un compose apte a complexer un ou plusieurs principes actifs
|
US6787142B2
(en)
|
2001-04-30 |
2004-09-07 |
Government Of Republic Of Singapore |
Mutant human hepatitis B viral strain and uses thereof
|
CN1255540C
(zh)
|
1998-06-19 |
2006-05-10 |
新加坡共和国政府 |
一株疫苗诱导的乙型肝炎病毒株及其应用
|
TR200003777T2
(tr)
|
1998-06-19 |
2001-06-21 |
Government Of Republic Of Singapore |
Mutant bir insan hepatit B virüsü türü ve bunun kullanımı
|
BR9912070A
(pt)
|
1998-07-13 |
2001-04-10 |
Expression Genetics Inc |
Análogo de poliéster de poli-l-lisina como um solúvel, veìculo de distribuição de gene biodegradável
|
EP1142906A1
(en)
|
2000-03-31 |
2001-10-10 |
Ortho-Clinical Diagnostics, Inc. |
A hepatitis B virus (subtype ayw) surface antigen variant
|
CA2413546C
(en)
|
2000-06-22 |
2011-06-14 |
Celltech Pharmaceuticals Limited |
Modification of hepatitis b core antigen
|
US7202354B2
(en)
|
2001-03-30 |
2007-04-10 |
Abbott Laboratories |
Hepatitis B virus surface antigen mutant and methods of detection thereof
|
DE60229003D1
(de)
|
2002-07-29 |
2008-10-30 |
Nanodel Technologies Gmbh |
Nanopartikele für dna verabreichung zu einem zielorgan
|
EP1572234B1
(en)
|
2002-12-10 |
2012-02-22 |
Sanofi Pasteur Biologics Co. |
STABILIZED IMMUNOGENIC HBc CHIMER PARTICLES
|
US7727969B2
(en)
|
2003-06-06 |
2010-06-01 |
Massachusetts Institute Of Technology |
Controlled release nanoparticle having bound oligonucleotide for targeted delivery
|
CA2880061C
(en)
*
|
2004-01-23 |
2018-03-13 |
Agostino Cirillo |
Chimpanzee adenovirus vaccine carriers
|
LT2612862T
(lt)
|
2004-05-13 |
2017-01-25 |
Icos Corporation |
Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės delta inhibitoriai
|
US7404969B2
(en)
|
2005-02-14 |
2008-07-29 |
Sirna Therapeutics, Inc. |
Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
|
TWI382019B
(zh)
|
2005-08-19 |
2013-01-11 |
Array Biopharma Inc |
作為類鐸受體(toll-like receptor)調節劑之胺基二氮雜呯
|
TWI404537B
(zh)
|
2005-08-19 |
2013-08-11 |
Array Biopharma Inc |
作為類鐸受體(toll-like receptor)調節劑之8-經取代苯并氮雜呯
|
EP1783228A1
(en)
|
2005-11-08 |
2007-05-09 |
ETH Zürich |
Recombinant expression of multiprotein complexes using polygenes
|
TWI399377B
(zh)
|
2006-07-07 |
2013-06-21 |
Gilead Sciences Inc |
類鐸受體7之調節劑
|
WO2008020656A1
(en)
|
2006-08-14 |
2008-02-21 |
Postech Foundation |
A dna vaccine for curing chronic hepatitis b and a method of preparing same
|
KR100836745B1
(ko)
|
2007-01-31 |
2008-06-10 |
(주)두비엘 |
Hbv 백신 및 그의 제조 방법
|
US7968544B2
(en)
|
2007-06-29 |
2011-06-28 |
Gilead Sciences, Inc. |
Modulators of toll-like receptor 7
|
US8138318B2
(en)
|
2007-09-13 |
2012-03-20 |
Abbott Laboratories |
Hepatitis B pre-S2 nucleic acid
|
CA2698812A1
(en)
|
2007-09-14 |
2009-03-19 |
Nitto Denko Corporation |
Drug carriers
|
DE102007062962A1
(de)
|
2007-12-21 |
2009-06-25 |
Siemens Healthcare Diagnostics Products Gmbh |
Neue Oberflächen-Protein-Mutante des Hepatitis B Virus HBV surface Antigen (HBsAg)
|
EP4186978A1
(en)
|
2007-12-27 |
2023-05-31 |
Universität Zürich |
Replication-defective arenavirus vectors
|
MY171866A
(en)
|
2008-07-08 |
2019-11-05 |
Incyte Holdings Corp |
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
|
AU2009276403B2
(en)
|
2008-08-01 |
2016-03-10 |
Ventirx Pharmaceuticals, Inc. |
Toll-like receptor agonist formulations and their use
|
TW201639852A
(zh)
|
2008-12-09 |
2016-11-16 |
吉李德科學股份有限公司 |
用於製備可用作類鐸受體調節劑之化合物的中間體化合物
|
WO2010120874A2
(en)
|
2009-04-14 |
2010-10-21 |
Chimeros, Inc. |
Chimeric therapeutics, compositions, and methods for using same
|
ES2693705T3
(es)
*
|
2009-07-02 |
2018-12-13 |
Merz Pharma Gmbh & Co. Kgaa |
Neurotoxinas que muestran actividad biológica reducida
|
KR20120052352A
(ko)
*
|
2009-08-07 |
2012-05-23 |
트랜스진 에스.에이. |
Hbv 감염을 치료하는 조성물
|
US10076570B2
(en)
*
|
2009-08-07 |
2018-09-18 |
Transgene S.A. |
Composition for treating HBV infection
|
DK2467380T3
(en)
|
2009-08-18 |
2017-03-13 |
Ventirx Pharmaceuticals Inc |
SUBSTITUTED BENZOAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS
|
ES2620629T3
(es)
|
2009-08-18 |
2017-06-29 |
Ventirx Pharmaceuticals, Inc. |
Benzoazepinas sustituidas como moduladores del receptor tipo Toll
|
US8962652B2
(en)
|
2009-10-22 |
2015-02-24 |
Gilead Sciences, Inc. |
Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
|
KR101230913B1
(ko)
|
2009-11-06 |
2013-02-07 |
중앙대학교 산학협력단 |
나노입자-기반된 유전자 운반체
|
SG177025A1
(en)
|
2010-06-21 |
2012-01-30 |
Agency Science Tech & Res |
Hepatitis b virus specific antibody and uses thereof
|
WO2011106106A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
|
MY189483A
(en)
|
2010-05-31 |
2022-02-16 |
Ono Pharmaceutical Co |
Purinone derivative
|
US8907053B2
(en)
|
2010-06-25 |
2014-12-09 |
Aurigene Discovery Technologies Limited |
Immunosuppression modulating compounds
|
KR101209266B1
(ko)
|
2010-06-30 |
2012-12-06 |
한국과학기술연구원 |
생분해성 및 온도 감응성 폴리포스파젠계 자성 고분자, 그의 제조 방법 및 용도
|
WO2012045090A2
(en)
|
2010-10-01 |
2012-04-05 |
Ventirx Pharmaceuticals, Inc. |
Therapeutic use of a tlr agonist and combination therapy
|
MX351464B
(es)
|
2010-10-01 |
2017-10-16 |
Ventirx Pharmaceuticals Inc Star |
El uso de un agonista del receptor 8 tipo toll para el tratamiento de enfermedades alérgicas.
|
UY33775A
(es)
|
2010-12-10 |
2012-07-31 |
Gilead Sciences Inc |
Inhibidores macrocíclicos de virus flaviviridae, composiciones farmacéuticas que los comprenden y sus usos
|
KR101308591B1
(ko)
|
2010-12-30 |
2013-09-13 |
주식회사 삼양바이오팜 |
양이온성 지질을 포함하는 음이온성 약물 전달체 및 그 제조방법
|
BR112013017947A2
(pt)
|
2011-01-12 |
2018-12-18 |
Array Biopharma Inc |
benzoazepinas substituídas como moduladores de receptor toll-like
|
PT2663550T
(pt)
|
2011-01-12 |
2017-03-22 |
Array Biopharma Inc |
Benzoazepinas substítuidas utilizáveis como moduladores dos recetores tipo toll
|
US9238679B2
(en)
|
2011-02-11 |
2016-01-19 |
The Trustees Of The University Of Pennslyvania |
Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
|
EA202092990A3
(ru)
|
2011-02-11 |
2021-07-30 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Молекула нуклеиновой кислоты, кодирующая коровый белок вируса гепатита в, и вакцина, содержащая указанную молекулу
|
CA2827150C
(en)
|
2011-02-12 |
2018-09-11 |
Globeimmune, Inc. |
Yeast-based therapeutic for chronic hepatitis b infection
|
RS62254B1
(sr)
|
2011-04-08 |
2021-09-30 |
Janssen Sciences Ireland Unlimited Co |
Derivati pirimidina za tretman virusnih infekcija
|
US8691750B2
(en)
|
2011-05-17 |
2014-04-08 |
Axolabs Gmbh |
Lipids and compositions for intracellular delivery of biologically active compounds
|
RS57023B1
(sr)
|
2011-05-18 |
2018-05-31 |
Janssen Sciences Ireland Uc |
Derivati hinazolina za tretman viralnih infekcija i drugih bolesti
|
GB201108879D0
(en)
|
2011-05-25 |
2011-07-06 |
Isis Innovation |
Vector
|
WO2012168944A1
(en)
|
2011-06-08 |
2012-12-13 |
Aurigene Discovery Technologies Limited |
Therapeutic compounds for immunomodulation
|
TWI575070B
(zh)
*
|
2011-07-12 |
2017-03-21 |
傳斯堅公司 |
Hbv聚合酶突變體
|
DE102011080362A1
(de)
|
2011-08-03 |
2013-02-07 |
Robert Bosch Gmbh |
Elektrisches Kontaktelement mit Rastlanze für ein Steckergehäuse
|
WO2013052699A2
(en)
|
2011-10-04 |
2013-04-11 |
Gilead Calistoga Llc |
Novel quinoxaline inhibitors of pi3k
|
KR101383324B1
(ko)
|
2011-11-10 |
2014-04-28 |
주식회사 종근당 |
신규한 유전자 전달용 조성물
|
US8945876B2
(en)
|
2011-11-23 |
2015-02-03 |
University Of Hawaii |
Auto-processing domains for polypeptide expression
|
PL2786996T3
(pl)
|
2011-11-29 |
2017-01-31 |
Ono Pharmaceutical Co., Ltd. |
Chlorowodorowa pochodna purynonu
|
JP6215223B2
(ja)
*
|
2011-12-09 |
2017-10-18 |
アンスティテュ・パストゥール |
マルチプレックス免疫スクリーニングアッセイ
|
SG11201402660YA
(en)
|
2011-12-21 |
2014-10-30 |
Novira Therapeutics Inc |
Hepatitis b antiviral agents
|
WO2013116562A1
(en)
|
2012-02-03 |
2013-08-08 |
Gilead Calistoga Llc |
Compositions and methods of treating a disease with (s)-4 amino-6-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile
|
ES2716811T3
(es)
|
2012-02-08 |
2019-06-17 |
Janssen Sciences Ireland Unlimited Co |
Derivados piperidinopirimidínicos para el tratamiento de infecciones víricas
|
EP2822957A1
(en)
|
2012-03-07 |
2015-01-14 |
Aurigene Discovery Technologies Limited |
Peptidomimetic compounds as immunomodulators
|
CA2868408A1
(en)
|
2012-03-29 |
2013-10-03 |
Aurigene Discovery Technologies Limited |
Immunomodulating cyclic compounds from the bc loop of human pd1
|
US20130267517A1
(en)
|
2012-03-31 |
2013-10-10 |
Hoffmann-La Roche Inc. |
Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
RU2014142598A
(ru)
|
2012-03-31 |
2016-05-27 |
Ф. Хоффманн-Ля Рош Аг |
Новые 4-метилдигидропиримидины для лечения и профилактики инфекции вируса гепатита в
|
KR20150040265A
(ko)
|
2012-06-08 |
2015-04-14 |
길리애드 사이언시즈, 인코포레이티드 |
플라비비리대 바이러스의 마크로시클릭 저해제
|
PT2859009T
(pt)
|
2012-06-08 |
2018-01-18 |
Gilead Sciences Inc |
Inibidores macrocíclicos dos vírus flaviviridae
|
AR091279A1
(es)
|
2012-06-08 |
2015-01-21 |
Gilead Sciences Inc |
Inhibidores macrociclicos de virus flaviviridae
|
KR101944263B1
(ko)
|
2012-06-11 |
2019-02-01 |
시아먼 유니버시티 |
에이치비브이 감염 및 관련 질병의 치료를 위한 폴리펩타이드 및 항체
|
KR102280589B1
(ko)
|
2012-08-10 |
2021-07-22 |
얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 |
바이러스 감염 또는 추가 질환의 치료를 위한 알킬피리미딘 유도체
|
EP2882706A1
(en)
|
2012-08-13 |
2015-06-17 |
Massachusetts Institute of Technology |
Amine-containing lipidoids and uses thereof
|
JP6285440B2
(ja)
|
2012-08-28 |
2018-02-28 |
ヤンセン・サイエンシズ・アイルランド・ユーシー |
融合二環式スルファモイル誘導体並びにb型肝炎の治療のための薬剤としてのその使用
|
KR102122244B1
(ko)
|
2012-08-28 |
2020-06-15 |
얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 |
설파모일-아릴아미드 및 b형 간염 치료제로서의 그 용도
|
MA37942B1
(fr)
|
2012-09-10 |
2020-01-31 |
Hoffmann La Roche |
Hétéroaryldihydropyrimidines d'acide 6-aminé pour le traitement et la prophylaxie d'une infection par le virus de l'hépatite b
|
CA2885969C
(en)
|
2012-10-02 |
2021-04-06 |
Epitherapeutics Aps |
Substitued pyridine derivatives and compositions thereof useful as inhibitors of histone demethylases
|
PT2906563T
(pt)
|
2012-10-10 |
2018-05-23 |
Janssen Sciences Ireland Uc |
Derivados de pirrolo[3,2-d]pirimidina para o tratamento de infeções virais e outras doenças
|
KR101268466B1
(ko)
|
2012-11-12 |
2013-06-04 |
유병수 |
사축형 윈드 터빈
|
DK2925729T3
(en)
|
2012-11-16 |
2018-01-22 |
Janssen Sciences Ireland Uc |
HETEROCYCLIC SUBSTITUTED 2-AMINOQUINAZOLINE DERIVATIVES FOR TREATING VIRUS INFECTIONS
|
CA2894399A1
(en)
|
2012-12-06 |
2014-06-12 |
Quanticel Pharmaceuticals, Inc. |
Histone demethylase inhibitors
|
PL2934145T3
(pl)
|
2012-12-19 |
2018-04-30 |
Celgene Quanticel Research, Inc. |
Inhibitory demetylazy histonowej
|
NZ708870A
(en)
|
2012-12-21 |
2016-09-30 |
Gilead Calistoga Llc |
Isoquinolinone or quinazolinone phosphatidylinositol 3-kinase inhibitors
|
CA2895782C
(en)
|
2012-12-21 |
2017-08-22 |
Gilead Calistoga Llc |
Substituted pyrimidine aminoalkyl-quinazolones as phosphatidylinositol 3-kinase inhibitors
|
CA2895808A1
(en)
|
2012-12-21 |
2014-06-26 |
Quanticel Pharmaceuticals, Inc. |
Histone demethylase inhibitors
|
KR102300861B1
(ko)
|
2013-02-21 |
2021-09-10 |
얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 |
바이러스 감염의 치료를 위한 2-아미노피리미딘 유도체
|
US9650339B2
(en)
|
2013-02-27 |
2017-05-16 |
Gilead Sciences, Inc. |
Inhibitors of histone demethylases
|
AU2014222641B2
(en)
|
2013-02-28 |
2018-03-15 |
Janssen Sciences Ireland Uc |
Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of Hepatitis B
|
WO2014165128A2
(en)
|
2013-03-12 |
2014-10-09 |
Novira Therapeutics, Inc. |
Hepatitis b antiviral agents
|
US9738637B2
(en)
|
2013-03-12 |
2017-08-22 |
Celgene Quantical Research, Inc. |
Histone demethylase inhibitors
|
CN105980386B
(zh)
|
2013-03-13 |
2021-08-13 |
基因泰克公司 |
吡唑并化合物及其用途
|
CN104043120B
(zh)
|
2013-03-13 |
2017-05-31 |
南京赛威信生物医药有限公司 |
乙型肝炎疫苗
|
CA2903081A1
(en)
|
2013-03-14 |
2014-09-25 |
Quanticel Pharmaceuticals, Inc. |
Histone demethylase inhibitors
|
JP2016513971A
(ja)
|
2013-03-14 |
2016-05-19 |
アルトラバックス インコーポレイテッド |
B型肝炎ウイルスワクチン
|
RS56561B1
(sr)
|
2013-03-15 |
2018-02-28 |
Quanticel Pharmaceuticals Inc |
Inhibitori histon demetilaze
|
US9308236B2
(en)
|
2013-03-15 |
2016-04-12 |
Bristol-Myers Squibb Company |
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
|
MX353412B
(es)
|
2013-04-03 |
2018-01-10 |
Janssen Sciences Ireland Uc |
Derivados de n-fenil-carboxamida y su uso como medicamentos para el tratamiento de la hepatitis b.
|
EP2983708A4
(en)
*
|
2013-04-08 |
2016-10-05 |
Medimmune Llc |
VACCINE COMPOSITION AND METHOD OF USE
|
EP2992000B1
(en)
|
2013-05-03 |
2020-07-08 |
The Regents of The University of California |
Cyclic di-nucleotide induction of type i interferon
|
AU2014267235B2
(en)
|
2013-05-17 |
2017-10-05 |
Janssen Sciences Ireland Uc |
Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
|
PE20151951A1
(es)
|
2013-05-17 |
2015-12-26 |
Hoffmann La Roche |
Heteroarildihidropirimidinas unidas por puentes en 6 para el tratamiento y la profilaxis de infeccion por el virus de la hepatitis b
|
JO3603B1
(ar)
|
2013-05-17 |
2020-07-05 |
Janssen Sciences Ireland Uc |
مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي
|
PL3008053T3
(pl)
|
2013-06-14 |
2018-08-31 |
Gilead Calistoga Llc |
Inhibitory 3-kinazy fosfatydyloinozytolu
|
CN108047115B
(zh)
|
2013-07-25 |
2021-06-29 |
爱尔兰詹森科学公司 |
经乙醛酰胺取代的吡咯酰胺衍生物及其作为药物用于治疗乙型肝炎的用途
|
ES2836881T3
(es)
|
2013-07-30 |
2021-06-28 |
Janssen Sciences Ireland Unlimited Co |
Derivados de tieno[3,2-d]pirimidinas para el tratamiento de infecciones virales
|
WO2015019284A2
(en)
|
2013-08-05 |
2015-02-12 |
Cambridge Enterprise Limited |
Inhibition of cxcr4 signaling in cancer immunotherapy
|
WO2015023958A1
(en)
|
2013-08-15 |
2015-02-19 |
The University Of Kansas |
Toll-like receptor agonists
|
ES2642074T3
(es)
|
2013-09-04 |
2017-11-15 |
Bristol-Myers Squibb Company |
Compuestos útiles como inmunomoduladores
|
SI3041468T1
(sl)
|
2013-09-06 |
2018-10-30 |
Aurigene Discovery Technologies Limited |
Ciklične peptidomimetične spojine kot imunomodulatorji
|
PT3041828T
(pt)
|
2013-09-06 |
2018-10-09 |
Aurigene Discovery Tech Ltd |
Derivados 1,3,4-0xadiazoles como imonomoduladores
|
ES2788848T3
(es)
|
2013-09-06 |
2020-10-23 |
Aurigene Discovery Tech Ltd |
Derivados de 1,2,4-oxadiazol como inmunomoduladores
|
WO2015036927A1
(en)
|
2013-09-10 |
2015-03-19 |
Aurigene Discovery Technologies Limited |
Immunomodulating peptidomimetic derivatives
|
DK3043865T3
(da)
|
2013-09-11 |
2021-02-01 |
Univ Claude Bernard Lyon |
Fremgangsmåder og farmaceutiske sammensætningr til behandlingen af hepatitis b-virusinfektion
|
WO2015044900A1
(en)
|
2013-09-27 |
2015-04-02 |
Aurigene Discovery Technologies Limited |
Therapeutic immunomodulating compounds
|
US9663486B2
(en)
|
2013-10-14 |
2017-05-30 |
Eisai R&D Management Co., Ltd. |
Selectively substituted quinoline compounds
|
MA39034B1
(fr)
|
2013-10-14 |
2018-09-28 |
Eisai R&D Man Co Ltd |
Composés de quinoline sélectivement substitués
|
EA034448B1
(ru)
|
2013-10-23 |
2020-02-10 |
Янссен Сайенсиз Айрлэнд Юси |
Производные карбоксамида и их применение в качестве медикаментов для лечения гепатита b
|
WO2015073774A1
(en)
|
2013-11-14 |
2015-05-21 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis b infections
|
EP3080124A1
(en)
|
2013-12-13 |
2016-10-19 |
Takeda Pharmaceutical Company Limited |
Pyrrolo[3,2-c]pyridine derivatives as tlr inhibitors
|
US10654807B2
(en)
|
2013-12-20 |
2020-05-19 |
The University Of Kansas |
Toll-like receptor 8 agonists
|
US9181288B2
(en)
|
2014-01-16 |
2015-11-10 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
US9169212B2
(en)
|
2014-01-16 |
2015-10-27 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
EP3099685B1
(en)
|
2014-01-30 |
2018-04-18 |
F.Hoffmann-La Roche Ag |
Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection
|
CN106456753B
(zh)
|
2014-02-04 |
2021-05-11 |
因塞特公司 |
用于治疗癌症的pd-1拮抗剂和ido1抑制剂的组合
|
US11078193B2
(en)
|
2014-02-06 |
2021-08-03 |
Janssen Sciences Ireland Uc |
Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
|
WO2015134605A1
(en)
|
2014-03-05 |
2015-09-11 |
Bristol-Myers Squibb Company |
Treatment of renal cancer using a combination of an anti-pd-1 antibody and another anti-cancer agent
|
EP3114128B1
(en)
|
2014-03-07 |
2019-01-02 |
F. Hoffmann-La Roche AG |
Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
US9400280B2
(en)
|
2014-03-27 |
2016-07-26 |
Novira Therapeutics, Inc. |
Piperidine derivatives and methods of treating hepatitis B infections
|
US9850225B2
(en)
|
2014-04-14 |
2017-12-26 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
EP3134402B1
(en)
|
2014-04-22 |
2020-05-06 |
F.Hoffmann-La Roche Ag |
4-amino-imidazoquinoline compounds
|
CR20160512A
(es)
|
2014-05-01 |
2016-12-21 |
Novartis Ag |
Compuestos y composiciones como agonistas del receptor tipo toll 7
|
CN106459058B
(zh)
|
2014-05-01 |
2019-07-05 |
诺华股份有限公司 |
作为toll-样受体7激动剂的化合物和组合物
|
JP6568106B2
(ja)
|
2014-05-13 |
2019-08-28 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
B型肝炎ウイルス感染症の治療及び予防のための新規ジヒドロキノリジノン類
|
BR112016026721A2
(pt)
*
|
2014-05-16 |
2017-10-31 |
Univ Yale |
vacinas com base em vesículas do tipo vírus (vlvs) para prevenir ou tratar infecção por vírus da hepatite b (hbv) crônica
|
KR102535283B1
(ko)
|
2014-05-23 |
2023-05-22 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
암의 치료를 위한 조합 요법
|
US10342861B2
(en)
|
2014-05-27 |
2019-07-09 |
University Of Rochester |
Arenavirus vaccine
|
US10987322B2
(en)
|
2014-06-06 |
2021-04-27 |
Flexus Biosciences, Inc. |
Immunoregulatory agents
|
WO2016012470A1
(en)
|
2014-07-25 |
2016-01-28 |
F. Hoffmann-La Roche Ag |
New amorphous and crystalline forms of (3s)-4-[[(4r)-4-(2-chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1, 4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic acid
|
US9943585B2
(en)
|
2014-07-30 |
2018-04-17 |
University Of Rochester |
Methods and compositions related to reorganization of arenavirus genome for development of novel arenavirus live-attenuated vaccines (LAV)
|
SG10201900886RA
(en)
|
2014-08-01 |
2019-03-28 |
3M Innovative Properties Co |
Methods and therapeutic combinations for treating tumors
|
WO2016023877A1
(en)
|
2014-08-14 |
2016-02-18 |
F. Hoffmann-La Roche Ag |
Novel pyridazones and triazinones for the treatment and prophylaxis of hepatitis b virus infection
|
EP3190113B1
(en)
|
2014-08-15 |
2021-05-19 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Pyrrolopyrimidine compounds used as tlr7 agonist
|
US20170275287A1
(en)
|
2014-08-22 |
2017-09-28 |
Janus Biotherapeutics, Inc. |
Novel n2, n4, n7, 6-tetrasubstituted pteridine-2,4,7-triamine and 2, 4, 6, 7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof
|
BR112017003442A2
(pt)
|
2014-08-27 |
2017-11-28 |
Gilead Sciences Inc |
compostos e métodos para inibir histona desmetilases
|
US9884866B2
(en)
|
2014-09-08 |
2018-02-06 |
Regents Of The University Of Minnesota |
Immunomodulators and immunomodulator conjugates
|
CA2960778C
(en)
|
2014-09-11 |
2023-03-07 |
Bristol-Myers Squibb Company |
Macrocyclic inhibitors of the pd-1/pd-l1 and cd80(b7-1)/pd-l1 protein/protein interactions
|
US9732119B2
(en)
|
2014-10-10 |
2017-08-15 |
Bristol-Myers Squibb Company |
Immunomodulators
|
CN107912040B
(zh)
|
2014-10-10 |
2021-04-06 |
基因泰克公司 |
作为组蛋白脱甲基酶抑制剂的吡咯烷酰胺化合物
|
CN107001386A
(zh)
|
2014-10-11 |
2017-08-01 |
豪夫迈·罗氏有限公司 |
用于治疗感染性疾病的化合物
|
US9637485B2
(en)
|
2014-11-03 |
2017-05-02 |
Hoffmann-La Roche Inc. |
6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection
|
UY36390A
(es)
|
2014-11-05 |
2016-06-01 |
Flexus Biosciences Inc |
Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen
|
SI3218504T1
(sl)
|
2014-11-13 |
2020-11-30 |
Universite De Geneve |
Tri-segmentirani arenavirusi kot vakcinski vektorji
|
CN107108628A
(zh)
|
2014-11-13 |
2017-08-29 |
葛兰素史密丝克莱恩生物有限公司 |
可用于治疗变应性疾病或其它炎性病症的腺嘌呤衍生物
|
US9856292B2
(en)
|
2014-11-14 |
2018-01-02 |
Bristol-Myers Squibb Company |
Immunomodulators
|
WO2016090470A1
(en)
|
2014-12-08 |
2016-06-16 |
Brian Chen |
Cleavable nucleic acid linkers for protein quantification ratioing
|
SI3230298T1
(sl)
|
2014-12-08 |
2021-04-30 |
F. Hoffmann-La Roche Ag |
Spojine 3-substituiranega 5-amino-6H-tiazolo(4,5-d)pirimidin-2,7-diona za zdravljenje ali preprečevanje okužbe z virusom
|
EP3233835B1
(en)
|
2014-12-18 |
2019-01-23 |
F.Hoffmann-La Roche Ag |
Benzazepine sulfonamide compounds
|
US9861680B2
(en)
|
2014-12-18 |
2018-01-09 |
Bristol-Myers Squibb Company |
Immunomodulators
|
US9944678B2
(en)
|
2014-12-19 |
2018-04-17 |
Bristol-Myers Squibb Company |
Immunomodulators
|
AR103222A1
(es)
|
2014-12-23 |
2017-04-26 |
Hoffmann La Roche |
Procedimiento para la preparación de análogos de 4-fenil-5-alcoxicarbonil-2-tiazol-2-il-1,4-dihidropirimidina
|
US9676793B2
(en)
|
2014-12-23 |
2017-06-13 |
Hoffmann-Laroche Inc. |
Co-crystals of 5-amino-2-oxothiazolo[4,5-d]pyrimidin-3(2H)-yl-5-hydroxymethyl tetrahydrofuran-3-yl acetate and methods for preparing and using the same
|
CN105732635A
(zh)
|
2014-12-29 |
2016-07-06 |
南京明德新药研发股份有限公司 |
一类Toll样受体7激动剂
|
CN107531691A
(zh)
|
2014-12-30 |
2018-01-02 |
诺维拉治疗公司 |
治疗乙型肝炎感染的衍生物和方法
|
WO2016107832A1
(en)
|
2014-12-30 |
2016-07-07 |
F. Hoffmann-La Roche Ag |
Novel tetrahydropyridopyrimidines and tetrahydropyridopyridines for the treatment and prophylaxis of hepatitis b virus infection
|
EP3240913A1
(en)
|
2014-12-31 |
2017-11-08 |
F. Hoffmann-La Roche AG |
A novel high-throughput method for quantification of hbv cccdna from cell lysate by real-time pcr
|
MA41338B1
(fr)
|
2015-01-16 |
2019-07-31 |
Hoffmann La Roche |
Composés de pyrazine pour le traitement de maladies infectieuses
|
JP2018502604A
(ja)
|
2015-01-27 |
2018-02-01 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
組換えHBV cccDNA、その作製方法およびその使用
|
WO2016128335A1
(en)
|
2015-02-11 |
2016-08-18 |
F. Hoffmann-La Roche Ag |
Novel 2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis b virus infection
|
CN107949397A
(zh)
*
|
2015-02-13 |
2018-04-20 |
特兰斯吉恩股份有限公司 |
免疫治疗疫苗和抗体组合治疗
|
SI3097102T1
(en)
|
2015-03-04 |
2018-02-28 |
Gilead Sciences, Inc. |
A TOOL RECEPTOR MODULING 4,6-DIAMINO-PYRIDO (3,2-D) PYRIMIDINE COMPOUNDS
|
MA41625A
(fr)
|
2015-03-06 |
2018-01-10 |
Hoffmann La Roche |
Composés de benzazépine dicarboxamide
|
CU20170117A7
(es)
|
2015-03-10 |
2018-05-08 |
Aurigene Discovery Tech Ltd |
COMPUESTOS TIADIAZOL y 1,3,4-OXADIAZOL 3-SUSTITUIDOS COMO INMUNOMODULADORES
|
CU24509B1
(es)
|
2015-03-10 |
2021-05-12 |
Aurigene Discovery Tech Ltd |
Compuestos de 1,2,4-oxadiazol y tiadiazol como inmunomoduladores
|
SG11201706901TA
(en)
|
2015-03-10 |
2017-09-28 |
Aurigene Discovery Tech Ltd |
Therapeutic cyclic compounds as immunomodulators
|
MX2017011614A
(es)
|
2015-03-10 |
2018-03-23 |
Aurigene Discovery Tech Ltd |
Compuestos de 1,3,4-oxadiazol y tiadiazol como inmunomoduladores.
|
JP2018507894A
(ja)
|
2015-03-10 |
2018-03-22 |
オーリジーン ディスカバリー テクノロジーズ リミテッドAurigene Discovery Technologies Limited |
免疫調節剤としての3−置換−1,2,4−オキサジアゾールおよびチアジアゾール化合物
|
US9809625B2
(en)
|
2015-03-18 |
2017-11-07 |
Bristol-Myers Squibb Company |
Immunomodulators
|
US10442788B2
(en)
|
2015-04-01 |
2019-10-15 |
Enanta Pharmaceuticals, Inc. |
Hepatitis B antiviral agents
|
CA2982811A1
(en)
|
2015-04-17 |
2016-10-20 |
Indiana University Research And Technology Corporation |
Hepatitis b viral assembly effectors
|
WO2016177655A1
(en)
|
2015-05-04 |
2016-11-10 |
F. Hoffmann-La Roche Ag |
Tetrahydropyridopyrimidines and tetrahydropyridopyridines as inhibitors of hbsag (hbv surface antigen) and hbv dna production for the treatment of hepatitis b virus infections
|
CA2984794A1
(en)
|
2015-05-07 |
2016-11-10 |
Agenus Inc. |
Anti-ox40 antibodies and methods of use thereof
|
CN107592864B
(zh)
|
2015-05-12 |
2021-04-16 |
豪夫迈·罗氏有限公司 |
用于治疗和预防病毒感染的新的取代的氨基噻唑并嘧啶二酮
|
MX2017015149A
(es)
*
|
2015-05-26 |
2018-03-28 |
Advaxis Inc |
Inmunoterapia personalizada basada en vectores de suministro y usos de esta.
|
WO2016195982A2
(en)
|
2015-06-01 |
2016-12-08 |
The Penn State Research Foundation |
Hepatitis b virus capsid assembly
|
US20160376864A1
(en)
|
2015-06-29 |
2016-12-29 |
Cameron International Corporation |
Apparatus and method for distributing fluids to a wellbore
|
WO2017001307A1
(en)
|
2015-06-30 |
2017-01-05 |
F. Hoffmann-La Roche Ag |
Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection
|
GB201511477D0
(en)
|
2015-06-30 |
2015-08-12 |
Redx Pharma Plc |
Antiviral compounds
|
US10875876B2
(en)
|
2015-07-02 |
2020-12-29 |
Janssen Sciences Ireland Uc |
Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
|
WO2017007701A1
(en)
|
2015-07-07 |
2017-01-12 |
Merck Sharp & Dohme Corp. |
Antiviral phosphodiamide compounds
|
WO2017013046A1
(en)
|
2015-07-21 |
2017-01-26 |
F. Hoffmann-La Roche Ag |
Novel tricyclic 4-pyridone-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis b virus infection
|
GB201513010D0
(en)
|
2015-07-23 |
2015-09-09 |
Glaxosmithkline Biolog Sa |
Novel formulation
|
WO2017016960A1
(en)
|
2015-07-24 |
2017-02-02 |
F. Hoffmann-La Roche Ag |
Process for the preparation of (6s)-6-alkyl-10-alkoxy-9-(substituted alkoxy)-2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid analogues
|
CN107820496B
(zh)
|
2015-07-27 |
2020-11-03 |
豪夫迈·罗氏有限公司 |
用于治疗和预防乙型肝炎病毒感染的新的四环4-氧代-吡啶-3-甲酸衍生物
|
JP6559324B2
(ja)
|
2015-07-28 |
2019-08-14 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
B型肝炎ウイルス感染の治療及び予防用の新規6,7−ジヒドロピリド[2,1−a]フタラジン−2−オン類
|
WO2017017624A1
(en)
|
2015-07-29 |
2017-02-02 |
Novartis Ag |
Combination of pd-1 antagonist with an egfr inhibitor
|
WO2017027434A1
(en)
|
2015-08-10 |
2017-02-16 |
Merck Sharp & Dohme Corp. |
Antiviral beta-amino acid ester phosphodiamide compounds
|
MX2018001814A
(es)
|
2015-08-13 |
2018-05-07 |
Merck Sharp & Dohme |
Compuestos dinucleotidos ciclicos como agonistas del estimulador de genes de interferon.
|
WO2017034986A1
(en)
|
2015-08-21 |
2017-03-02 |
University Of Kansas |
Human tlr8-selective agonists
|
WO2017038909A1
(en)
|
2015-08-28 |
2017-03-09 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compounds
|
MX2018002017A
(es)
|
2015-08-31 |
2018-03-26 |
3M Innovative Properties Co |
Compuestos de anillo de imidazo[4,5-c] sustituido con guanidina.
|
CA2996797A1
(en)
|
2015-09-04 |
2017-03-09 |
Tocagen Inc. |
Recombinant vectors comprising 2a peptide
|
TW201720802A
(zh)
|
2015-09-15 |
2017-06-16 |
艾森伯利生物科學公司 |
B型肝炎核心蛋白質調節劑
|
CA2997955A1
(en)
|
2015-09-15 |
2017-03-23 |
Gilead Sciences, Inc. |
Modulators of toll-like receptors for the treatment of hiv
|
WO2017047769A1
(ja)
|
2015-09-17 |
2017-03-23 |
国立大学法人富山大学 |
トール様受容体7またはトール様受容体9の活性化阻害剤
|
CN108055842B
(zh)
|
2015-09-17 |
2021-06-29 |
豪夫迈·罗氏有限公司 |
亚磺酰基苯基或磺亚胺酰基苯基苯并氮杂䓬
|
WO2017061466A1
(ja)
|
2015-10-05 |
2017-04-13 |
富山化学工業株式会社 |
抗b型肝炎ウイルス剤
|
EP3868741B1
(en)
|
2015-10-07 |
2023-08-30 |
Sumitomo Pharma Co., Ltd. |
Composition comprising a pyrimidine compound and a pathogen derived antigen
|
US10745382B2
(en)
|
2015-10-15 |
2020-08-18 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
MA52119A
(fr)
|
2015-10-19 |
2018-08-29 |
Ncyte Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
CN108430503A
(zh)
|
2015-10-28 |
2018-08-21 |
艾杜罗生物科技公司 |
用于激活“干扰素基因刺激物”依赖性信号传导的组合物和方法
|
CN114748474A
(zh)
|
2015-11-04 |
2022-07-15 |
因赛特公司 |
用于吲哚胺2,3-双加氧酶抑制及其适应症的药物组合物和方法
|
DK3371316T3
(da)
*
|
2015-11-04 |
2023-01-23 |
Hookipa Biotech Gmbh |
Vacciner mod hepatitis b-virus
|
EP3381918B1
(en)
|
2015-11-05 |
2020-09-16 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
7-(thiazol-5-yl) pyrrolopyrimidine compound as tlr7 agonist
|
EP3377532B1
(en)
|
2015-11-19 |
2022-07-27 |
Bristol-Myers Squibb Company |
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (gitr) and uses thereof
|
SG11201804152RA
(en)
|
2015-11-19 |
2018-06-28 |
Incyte Corp |
Heterocyclic compounds as immunomodulators
|
WO2017096276A1
(en)
|
2015-12-02 |
2017-06-08 |
Agenus Inc. |
Anti-gitr antibodies and methods of use thereof
|
EP3383914A4
(en)
|
2015-12-02 |
2019-10-30 |
Agenus Inc. |
ANTI-OX40 ANTIBODIES AND METHODS OF USE
|
EP3383430A4
(en)
|
2015-12-02 |
2019-12-18 |
Agenus Inc. |
ANTIBODIES AND METHOD FOR USE THEREOF
|
EP3383431A4
(en)
|
2015-12-02 |
2019-08-28 |
Agenus Inc. |
ANTI-GITR ANTIBODIES AND METHOD OF USE THEREOF
|
PE20181297A1
(es)
|
2015-12-03 |
2018-08-07 |
Glaxosmithkline Ip Dev Ltd |
Dinucleotidos de purino ciclico como moduladores de sting
|
US20200079862A1
(en)
|
2015-12-03 |
2020-03-12 |
Agenus Inc. |
Anti-ox40 antibodies and methods of use thereof
|
EP3386512B1
(en)
|
2015-12-10 |
2023-11-22 |
Merck Sharp & Dohme LLC |
Antiviral phosphodiamide prodrugs of tenofovir
|
WO2017106740A1
(en)
|
2015-12-16 |
2017-06-22 |
Aduro Biotech, Inc. |
Methods for identifying inhibitors of "stimulator of interferon gene"-dependent interferon production
|
TW201726623A
(zh)
|
2015-12-17 |
2017-08-01 |
英塞特公司 |
作為免疫調節劑之雜環化合物
|
SG11201804170RA
(en)
|
2015-12-17 |
2018-06-28 |
Merck Patent Gmbh |
Polycyclic tlr7/8 antagonists and use thereof in the treatment of immune disorders
|
EP4292650A3
(en)
|
2015-12-22 |
2024-02-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
WO2017132332A1
(en)
|
2016-01-28 |
2017-08-03 |
Svenska Vaccinfabriken Produktion Ab |
Chimeric hepatitis d virus antigen and hepatitis b virus pre s1 genes for use alone or in vaccines contaning hepatitis b virus genes
|
JOP20170045B1
(ar)
|
2016-02-19 |
2021-08-17 |
Novartis Ag |
مركبات بيريدون رباعية الحلقة كمضادات فيروسية
|
CN109475570B
(zh)
|
2016-03-18 |
2022-04-01 |
免疫传感器公司 |
环二核苷酸化合物及使用方法
|
US10662177B2
(en)
|
2016-03-21 |
2020-05-26 |
Council Of Scientific & Industrial Research |
Blocking toll-like receptor 9 signaling with small molecule antagonist
|
US10358463B2
(en)
|
2016-04-05 |
2019-07-23 |
Bristol-Myers Squibb Company |
Immunomodulators
|
MX2018012249A
(es)
|
2016-04-19 |
2019-02-07 |
Innate Tumor Immunity Inc |
Moduladores de nlpr3.
|
WO2017184735A1
(en)
|
2016-04-19 |
2017-10-26 |
Ifm Therapeutics, Inc |
Nlrp3 modulators
|
WO2017186711A1
(en)
|
2016-04-25 |
2017-11-02 |
Invivogen |
Novel complexes of immunostimulatory compounds, and uses thereof
|
ES2907981T3
(es)
|
2016-05-06 |
2022-04-27 |
Shanghai De Novo Pharmatech Co Ltd |
Derivado de benzazepina, método de preparación, composición farmacéutica y uso del mismo
|
AR108396A1
(es)
|
2016-05-06 |
2018-08-15 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
IL262963B1
(en)
|
2016-05-18 |
2024-09-01 |
Hookipa Biotech Gmbh |
Three-segmented PICHINDE viruses as vaccine vectors
|
CN109153682B
(zh)
|
2016-05-20 |
2021-05-25 |
豪夫迈·罗氏有限公司 |
用于治疗感染性疾病的具有氧、硫和氮连接基的新的吡嗪化合物
|
EP3464245B1
(en)
|
2016-05-23 |
2020-10-14 |
H. Hoffnabb-La Roche Ag |
Benzazepine dicarboxamide compounds with tertiary amide function
|
WO2017202703A1
(en)
|
2016-05-23 |
2017-11-30 |
F. Hoffmann-La Roche Ag |
Benzazepine dicarboxamide compounds with secondary amide function
|
EP3464278B1
(en)
|
2016-05-26 |
2021-06-16 |
F. Hoffmann-La Roche AG |
Xanthone derivatives for the treatment and prophylaxis of hepatitis b virus disease
|
WO2017205464A1
(en)
|
2016-05-26 |
2017-11-30 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
WO2017211791A1
(en)
|
2016-06-07 |
2017-12-14 |
F. Hoffmann-La Roche Ag |
Combination therapy of an hbsag inhibitor and a tlr7 agonist
|
CN109843296A
(zh)
|
2016-06-10 |
2019-06-04 |
英安塔制药有限公司 |
乙型肝炎抗病毒药剂
|
JP7012668B2
(ja)
|
2016-06-12 |
2022-02-14 |
エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト |
ジヒドロピリミジニルベンズアゼピンジカルボキサミド化合物
|
WO2017216685A1
(en)
|
2016-06-16 |
2017-12-21 |
Novartis Ag |
Pentacyclic pyridone compounds as antivirals
|
WO2017216686A1
(en)
|
2016-06-16 |
2017-12-21 |
Novartis Ag |
8,9-fused 2-oxo-6,7-dihydropyrido-isoquinoline compounds as antivirals
|
KR102685249B1
(ko)
|
2016-06-20 |
2024-07-17 |
인사이트 코포레이션 |
면역조절제로서의 복소환식 화합물
|
WO2017219931A1
(zh)
|
2016-06-22 |
2017-12-28 |
四川科伦博泰生物医药股份有限公司 |
二氢蝶啶酮类衍生物、其制备方法及其用途
|
GB2549809C
(en)
|
2016-06-23 |
2022-11-30 |
Univ Oxford Innovation Ltd |
Vector
|
EP3478692B1
(en)
|
2016-06-29 |
2020-06-17 |
Novira Therapeutics Inc. |
Oxadiazepinone derivatives and their use in the treatment of hepatitis b infections
|
US10071079B2
(en)
|
2016-06-29 |
2018-09-11 |
Bristol-Myers Squibb Company |
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
|
ES2900299T3
(es)
|
2016-06-29 |
2022-03-16 |
Novira Therapeutics Inc |
Derivados de diazepinona y su uso en el tratamiento de infecciones de hepatitis B
|
EP3478680B1
(en)
|
2016-06-29 |
2020-04-22 |
H. Hoffnabb-La Roche Ag |
Novel tetrahydropyridopyrimidines for the treatment and prophylaxis of hbv infection
|
JP6821716B2
(ja)
|
2016-06-29 |
2021-01-27 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
B型肝炎ウイルス感染の処置および予防のための新規のジヒドロピロロピリミジン
|
KR102468272B1
(ko)
|
2016-06-30 |
2022-11-18 |
삼성전자주식회사 |
음향 출력 장치 및 그 제어 방법
|
JP7171444B2
(ja)
|
2016-07-01 |
2022-11-15 |
ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー |
ウイルス感染治療用のジヒドロピラノピリミジン
|
JP6301402B2
(ja)
|
2016-07-01 |
2018-03-28 |
日新製鋼株式会社 |
フェライト系ステンレス鋼板およびその製造方法
|
US11098077B2
(en)
|
2016-07-05 |
2021-08-24 |
Chinook Therapeutics, Inc. |
Locked nucleic acid cyclic dinucleotide compounds and uses thereof
|
EP3481815B1
(en)
|
2016-07-08 |
2021-09-29 |
Bristol-Myers Squibb Company |
1,3-dihydroxy-phenyl derivatives useful as immunomodulators
|
WO2018011160A1
(en)
|
2016-07-14 |
2018-01-18 |
F. Hoffmann-La Roche Ag |
6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine compounds for the treatment of infectious diseases
|
EP3484886B1
(en)
|
2016-07-14 |
2020-03-04 |
Hoffmann-La Roche AG |
6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine and 6,7-dihydro-4h-triazolo[1,5-a]pyrazine compounds for the treatment of infectious diseases
|
MA45669A
(fr)
|
2016-07-14 |
2019-05-22 |
Incyte Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
WO2018011100A1
(en)
|
2016-07-14 |
2018-01-18 |
F. Hoffmann-La Roche Ag |
Novel tetrahydropyrazolopyridine compounds for the treatment of infectious diseases
|
WO2018011162A1
(en)
|
2016-07-14 |
2018-01-18 |
F. Hoffmann-La Roche Ag |
Carboxy 6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine compounds for the treatment of infectious diseases
|
WO2018019297A1
(zh)
|
2016-07-29 |
2018-02-01 |
银杏树药业(苏州)有限公司 |
异喹啉酮类化合物及其制备抗病毒药物的应用
|
CN110240596B
(zh)
|
2016-07-29 |
2020-09-11 |
新波制药有限公司 |
用于治疗hbv感染的治疗剂
|
SG11201900619XA
(en)
|
2016-07-30 |
2019-02-27 |
Bristol Myers Squibb Co |
Dimethoxyphenyl substituted indole compounds as tlr7, tlr8 or tlr9 inhibitors
|
CA3030773A1
(en)
|
2016-08-03 |
2018-02-08 |
Arising International, Inc. |
Symmetric or semi-symmetric compounds useful as immunomodulators
|
CN109689059A
(zh)
|
2016-08-24 |
2019-04-26 |
豪夫迈·罗氏有限公司 |
Hbv衣壳组装抑制剂和核苷或核苷酸类似物的组合疗法
|
AU2017314909B2
(en)
|
2016-08-26 |
2020-01-02 |
Solventum Intellectual Properties Company |
Fused [1,2]Imidazo[4,5-c] ring compounds substituted with guanidino groups
|
JOP20190024A1
(ar)
|
2016-08-26 |
2019-02-19 |
Gilead Sciences Inc |
مركبات بيروليزين بها استبدال واستخداماتها
|
US20180057486A1
(en)
|
2016-08-29 |
2018-03-01 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
US10144706B2
(en)
|
2016-09-01 |
2018-12-04 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
ES2826748T3
(es)
|
2016-09-02 |
2021-05-19 |
Gilead Sciences Inc |
Derivados de 4,6-diamino-pirido[3,2-d]pirimidina como moduladores de receptores de tipo Toll
|
US10370342B2
(en)
|
2016-09-02 |
2019-08-06 |
Gilead Sciences, Inc. |
Toll like receptor modulator compounds
|
WO2018043747A1
(ja)
|
2016-09-05 |
2018-03-08 |
国立大学法人京都大学 |
抗b型肝炎ウイルス剤
|
WO2018046460A1
(en)
|
2016-09-07 |
2018-03-15 |
Glaxosmithkline Biologicals S.A. |
Imidazoquinoline derivatives and their use in therapy
|
CU24526B1
(es)
|
2016-09-09 |
2021-06-08 |
Novartis Ag |
Compuestos inhibidores de los receptores endosomales tipo peaje
|
EP3510024B1
(en)
|
2016-09-09 |
2021-11-17 |
Bristol-Myers Squibb Company |
Pyridyl substituted indole compounds
|
TWI670266B
(zh)
|
2016-09-09 |
2019-09-01 |
大陸商浙江海正藥業股份有限公司 |
二氫嘧啶類化合物及其製備方法和用途
|
WO2018051254A1
(en)
|
2016-09-14 |
2018-03-22 |
Aurigene Discovery Technologies Limited |
Cyclic substituted-1,2,4-oxadiazole compounds as immunomodulators
|
WO2018051255A1
(en)
|
2016-09-14 |
2018-03-22 |
Aurigene Discovery Technologies Limited |
Cyclic substituted-1,3,4-oxadiazole and thiadiazole compounds as immunomodulators
|
US10537590B2
(en)
|
2016-09-30 |
2020-01-21 |
Boehringer Ingelheim International Gmbh |
Cyclic dinucleotide compounds
|
LT3523287T
(lt)
|
2016-10-04 |
2021-11-10 |
Merck Sharp & Dohme Corp. |
Benzo[b]tiofeno junginiai, kaip sting agonistai
|
US11001605B2
(en)
|
2016-10-07 |
2021-05-11 |
Biolog Life Science Institute Gmbh & Co. Kg |
Cyclic dinucleotides containing benzimidazole, method for the production of same, and use of same to activate stimulator of interferon genes (sting)-dependent signaling pathways
|
US10662416B2
(en)
|
2016-10-14 |
2020-05-26 |
Precision Biosciences, Inc. |
Engineered meganucleases specific for recognition sequences in the hepatitis B virus genome
|
AU2017345500B2
(en)
|
2016-10-20 |
2022-03-10 |
Aurigene Oncology Limited |
Dual inhibitors of vista and PD-1 pathways
|
US10736908B2
(en)
|
2016-10-26 |
2020-08-11 |
Merck Sharp & Dohme Corp. |
Antiviral aryl-amide phosphodiamide compounds
|
WO2018078149A1
(en)
|
2016-10-31 |
2018-05-03 |
F. Hoffmann-La Roche Ag |
Novel cyclicsulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection
|
KR102526034B1
(ko)
|
2016-11-07 |
2023-04-25 |
브리스톨-마이어스 스큅 컴퍼니 |
면역조정제
|
EP3538152A4
(en)
|
2016-11-09 |
2020-09-30 |
Agenus Inc. |
ANTI-OX40 ANTIBODIES, ANTI-GITR ANTIBODIES AND METHOD OF USING THEREOF
|
WO2018089695A1
(en)
|
2016-11-11 |
2018-05-17 |
Dynavax Technologies Corporation |
Toll-like receptor antagonist compounds and methods of use
|
EP3539963A4
(en)
|
2016-11-11 |
2020-05-13 |
Hepo Pharmaceutical Co., Ltd. |
NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PREPARATION METHOD, INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND USE
|
JOP20170188A1
(ar)
|
2016-11-25 |
2019-01-30 |
Janssen Biotech Inc |
ثنائي النوكليوتيدات الحلقية كمنبهات ستينغ (sting)
|
JP7145854B2
(ja)
|
2016-11-28 |
2022-10-03 |
ジエンス ヘンルイ メデイシンカンパニー リミテッド |
ピラゾロ‐ヘテロアリール誘導体、その製造方法及び医学的用途
|
JOP20170192A1
(ar)
|
2016-12-01 |
2019-01-30 |
Takeda Pharmaceuticals Co |
داي نوكليوتيد حلقي
|
JP2020503303A
(ja)
|
2016-12-20 |
2020-01-30 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
がんの処置のための環状ジヌクレオチドstingアゴニスト
|
RU2019122602A
(ru)
|
2016-12-20 |
2021-01-22 |
Мерк Шарп И Доум Корп. |
Комбинации антагонистов pd-1 и циклических динуклеотидных агонистов sting для лечения рака
|
KR102599339B1
(ko)
|
2016-12-20 |
2023-11-08 |
브리스톨-마이어스 스큅 컴퍼니 |
면역조정제로서 유용한 화합물
|
WO2018119286A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Bicyclic heteroaromatic compounds as immunomodulators
|
US10308644B2
(en)
|
2016-12-22 |
2019-06-04 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
RU2759902C2
(ru)
|
2016-12-22 |
2021-11-18 |
Мерк Шарп И Доум Корп. |
Антивирусные алифатические сложноэфирные пролекарства тенофовира
|
WO2018119221A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Pyridine derivatives as immunomodulators
|
US20180177784A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
US20180179201A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
WO2018118826A1
(en)
|
2016-12-22 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Antiviral benzyl-amine phosphodiamide compounds
|
GB201705765D0
(en)
*
|
2017-04-10 |
2017-05-24 |
Univ Oxford Innovation Ltd |
HBV vaccine
|
JOP20180040A1
(ar)
|
2017-04-20 |
2019-01-30 |
Gilead Sciences Inc |
مثبطات pd-1/pd-l1
|
CN111479926A
(zh)
|
2017-10-16 |
2020-07-31 |
葛兰素史密丝克莱恩生物有限公司 |
具有两个表达盒的猿猴腺病毒载体
|
JP2020537525A
(ja)
|
2017-10-16 |
2020-12-24 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
複製能力のあるアデノウイルスベクター
|
GB201721069D0
(en)
|
2017-12-15 |
2018-01-31 |
Glaxosmithkline Biologicals Sa |
Hepatitis B Immunisation regimen and compositions
|
GB201721068D0
(en)
|
2017-12-15 |
2018-01-31 |
Glaxosmithkline Biologicals Sa |
Hepatitis B immunisation regimen and compositions
|
EA202091513A1
(ru)
*
|
2017-12-19 |
2020-09-09 |
Янссен Сайенсиз Айрлэнд Анлимитед Компани |
Вакцины против вируса гепатита b (hbv) и их применение
|
EA202091516A1
(ru)
|
2017-12-19 |
2020-11-03 |
Янссен Сайенсиз Айрлэнд Анлимитед Компани |
Способы и композиции для индукции иммунного ответа против вируса гепатита b (hbv)
|
BR112020013715A2
(pt)
|
2018-01-05 |
2020-12-01 |
Ottawa Hospital Research Institute |
vetores de vaccinia modificados
|
PL3752501T3
(pl)
|
2018-02-13 |
2023-08-21 |
Gilead Sciences, Inc. |
Inhibitory pd-1/pd-l1
|
US11142750B2
(en)
|
2018-04-12 |
2021-10-12 |
Precision Biosciences, Inc. |
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
|
KR20230159715A
(ko)
|
2018-07-13 |
2023-11-21 |
길리애드 사이언시즈, 인코포레이티드 |
Pd-1/pd-l1 억제제
|
WO2020255023A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Arenavirus vectors for hepatitis b virus (hbv) vaccines and uses thereof
|
CN114729010A
(zh)
|
2019-08-29 |
2022-07-08 |
维尔生物科技有限公司 |
乙型肝炎病毒疫苗
|
BR112022005687A2
(pt)
|
2019-09-30 |
2022-06-21 |
Gilead Sciences Inc |
Vacinas contra o hbv e métodos para tratar o hbv
|